help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liaw, C. W.
Right arrow Articles by Maki, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liaw, C. W.
Right arrow Articles by Maki, R. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*UniGene
*Substance via MeSH
Molecular Endocrinology 11 (7): 980-985
Copyright © 1997 by The Endocrine Society

Localization of Ligand-Binding Domains of Human Corticotropin-Releasing Factor Receptor: A Chimeric Receptor Approach

Chen W. Liaw, Dimitri E. Grigoriadis, Timothy W. Lovenberg, Errol B. De Souza and Richard A. Maki

Departments of Molecular Neurobiology and Neuroscience, Neurocrine Biosciences, Inc., San Diego, California 92121

Two CRF receptors, CRFR1 and CRFR2, have recently been cloned and characterized. CRFR1 shares 70% sequence identity with CRFR2, yet has much higher affinity for rat/human CRF (r/hCRF) than CRFR2. As a first step toward understanding the interactions between rat/human CRF and its receptor, the regions that are involved in receptor-ligand binding and/or receptor activation were determined by using chimeric receptor constructs of the two human CRFR subtypes, CRFR1 and CRFR2, followed by generating point mutations of the receptor. The EC50 values in stimulation of intracellular cAMP of the chimeric and mutant receptors for the peptide ligand were determined using a cAMP-dependent reporter system. Three regions of the receptor were found to be important for optimal binding of r/hCRF and/or receptor activation. The first region was mapped to the junction of the third extracellular domain and the fifth transmembrane domain; substitution of three amino acids of CRFR1 in this region (Val266, Tyr267, and Thr268) by the corresponding CRFR2 amino acids (Asp266, Leu267, and Val268) increased the EC50 value by approximately 10-fold. The other two regions were localized to the second extracellular domain of the CRFR1 involving amino acids 175–178 and His189 residue. Substitutions in these two regions each increased the EC50 value for r/hCRF by approximately 7- to 8-fold only in the presence of the amino acid 266–268 mutation involving the first region, suggesting that their roles in peptide ligand binding might be secondary.




This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
K. Gkountelias, T. Tselios, M. Venihaki, G. Deraos, I. Lazaridis, O. Rassouli, A. Gravanis, and G. Liapakis
Alanine Scanning Mutagenesis of the Second Extracellular Loop of Type 1 Corticotropin-Releasing Factor Receptor Revealed Residues Critical for Peptide Binding
Mol. Pharmacol., April 1, 2009; 75(4): 793 - 800.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. Assil-Kishawi, T. A. Samra, D. F. Mierke, and A. B. Abou-Samra
Residue 17 of Sauvagine Cross-links to the First Transmembrane Domain of Corticotropin-releasing Factor Receptor 1 (CRFR1)
J. Biol. Chem., December 19, 2008; 283(51): 35644 - 35651.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. A. Pioszak, N. R. Parker, K. Suino-Powell, and H. E. Xu
Molecular Recognition of Corticotropin-releasing Factor by Its G-protein-coupled Receptor CRFR1
J. Biol. Chem., November 21, 2008; 283(47): 32900 - 32912.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
E. W. Hillhouse and D. K. Grammatopoulos
The Molecular Mechanisms Underlying the Regulation of the Biological Activity of Corticotropin-Releasing Hormone Receptors: Implications for Physiology and Pathophysiology
Endocr. Rev., May 1, 2006; 27(3): 260 - 286.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. J. Perry, S. Junger, T. A. Kohout, S. R. J. Hoare, R. S. Struthers, D. E. Grigoriadis, and R. A. Maki
Distinct Conformations of the Corticotropin Releasing Factor Type 1 Receptor Adopted following Agonist and Antagonist Binding Are Differentially Regulated
J. Biol. Chem., March 25, 2005; 280(12): 11560 - 11568.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. T. Weiss, S. L. Lake, E. S. Silverman, E. K. Silverman, B. Richter, J. M. Drazen, and K. G. Tantisira
Asthma Steroid Pharmacogenetics: A Study Strategy to Identify Replicated Treatment Responses
Proceedings of the ATS, December 1, 2004; 1(4): 364 - 367.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
K. G. Tantisira, S. Lake, E. S. Silverman, L. J. Palmer, R. Lazarus, E. K. Silverman, S. B. Liggett, E. W. Gelfand, L. J. Rosenwasser, B. Richter, et al.
Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids
Hum. Mol. Genet., July 1, 2004; 13(13): 1353 - 1359.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
R. C. Gensure, N. Shimizu, J. Tsang, and T. J. Gardella
Identification of a Contact Site for Residue 19 of Parathyroid Hormone (PTH) and PTH-Related Protein Analogs in Transmembrane Domain Two of the Type 1 PTH Receptor
Mol. Endocrinol., December 1, 2003; 17(12): 2647 - 2658.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. H. Perrin, M. R. DiGruccio, S. C. Koerber, J. E. Rivier, K. S. Kunitake, D. L. Bain, W. H. Fischer, and W. W. Vale
A Soluble Form of the First Extracellular Domain of Mouse Type 2beta Corticotropin-releasing Factor Receptor Reveals Differential Ligand Specificity
J. Biol. Chem., April 25, 2003; 278(18): 15595 - 15600.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. R. J. Hoare, S. K. Sullivan, N. Ling, P. D. Crowe, and D. E. Grigoriadis
Mechanism of Corticotropin-Releasing Factor Type I Receptor Regulation by Nonpeptide Antagonists
Mol. Pharmacol., March 1, 2003; 63(3): 751 - 765.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. Assil-Kishawi and A. B. Abou-Samra
Sauvagine Cross-links to the Second Extracellular Loop of the Corticotropin-releasing Factor Type 1 Receptor
J. Biol. Chem., August 30, 2002; 277(36): 32558 - 32561.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
F. M. Dautzenberg, J. Higelin, O. Brauns, B. Butscha, and R. L. Hauger
Five Amino Acids of the Xenopus laevis CRF (Corticotropin-Releasing Factor) Type 2 Receptor Mediate Differential Binding of CRF Ligands in Comparison with Its Human Counterpart
Mol. Pharmacol., May 1, 2002; 61(5): 1132 - 1139.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
G. Xu, C. Rabadan-Diehl, M. Nikodemova, P. Wynn, J. Spiess, and G. Aguilera
Inhibition of Corticotropin Releasing Hormone Type-1 Receptor Translation by an Upstream AUG Triplet in the 5' Untranslated Region
Mol. Pharmacol., March 1, 2001; 59(3): 485 - 492.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
F. M. Dautzenberg, G. Py-Lang, J. Higelin, C. Fischer, M. B. Wright, and G. Huber
Different Binding Modes of Amphibian and Human Corticotropin-Releasing Factor Type 1 and Type 2 Receptors: Evidence for Evolutionary Differences
J. Pharmacol. Exp. Ther., January 1, 2001; 296(1): 113 - 120.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
D. K. Grammatopoulos, H. S. Randeva, M. A. Levine, E. S. Katsanou, and E. W. Hillhouse
Urocortin, but Not Corticotropin-Releasing Hormone (CRH), Activates the Mitogen-Activated Protein Kinase Signal Transduction Pathway in Human Pregnant Myometrium: An Effect Mediated via R1{{alpha}} and R2{beta} CRH Receptor Subtypes and Stimulation of Gq-Proteins
Mol. Endocrinol., December 1, 2000; 14(12): 2076 - 2091.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
D. K. Grammatopoulos, Y. Dai, H. S. Randeva, M. A. Levine, E. Karteris, A. J. Easton, and E. W. Hillhouse
A Novel Spliced Variant of the Type 1 Corticotropin-Releasing Hormone Receptor with a Deletion in the Seventh Transmembrane Domain Present in the Human Pregnant Term Myometrium and Fetal Membranes
Mol. Endocrinol., December 1, 1999; 13(12): 2189 - 2202.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
V. I. DeAlmeida and K. E. Mayo
Identification of Binding Domains of the Growth Hormone-Releasing Hormone Receptor by Analysis of Mutant and Chimeric Receptor Proteins
Mol. Endocrinol., May 1, 1998; 12(5): 750 - 765.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
F. M. Dautzenberg, S. Wille, R. Lohmann, and J. Spiess
Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: Implications for the ligand-binding site
PNAS, April 28, 1998; 95(9): 4941 - 4946.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
C. W. Liaw, D. E. Grigoriadis, M. T. Lorang, E. B. De Souza, and R. A. Maki
Localization of Agonist- and Antagonist-Binding Domains of Human Corticotropin-Releasing Factor Receptors
Mol. Endocrinol., December 1, 1997; 11(13): 2048 - 2053.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. H. Perrin, W. H. Fischer, K. S. Kunitake, A. G. Craig, S. C. Koerber, L. A. Cervini, J. E. Rivier, J. C. Groppe, J. Greenwald, S. M. Nielsen, et al.
Expression, Purification, and Characterization of a Soluble Form of the First Extracellular Domain of the Human Type 1 Corticotropin Releasing Factor Receptor
J. Biol. Chem., August 17, 2001; 276(34): 31528 - 31534.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society